Literature DB >> 6295158

The antifungal activity of ketoconazole.

J Van Cutsem.   

Abstract

The antifungal properties of ketoconazole were investigated both in vitro and in vivo. The antifungal potency of ketoconazole in vitro was studied in Sabouraud's broth for 715 fungal strains belonging to 85 species and several strains were tested in other media, including Eagle's minimal essential medium. Ketoconazole is highly active in vitro and possesses broadspectrum activity. Its in vitro activity is largely dependent on the medium used. Ketoconazole's activity is increased in medium enriched with serum and in Eagle's minimal essential medium. Ketoconazole is very potent in the topical treatment of skin dermatophytosis, skin candidiasis, and in vaginal candidiasis of laboratory animals. Ketoconazole is superior to griseofulvin in the oral treatment of skin dermatophytosis. Furthermore, ketoconazole is orally highly active in skin candidiasis in guinea pigs, in vaginal candidiasis in rats, and in gastrointestinal candidiasis in various animal animal species. In systemic candidiasis and in disseminated dermatophytosis in guinea pigs cure with oral ketoconazole is achieved. No side effects are observed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6295158     DOI: 10.1016/0002-9343(83)90508-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

1.  Systemic candidiasis in heroin addicts.

Authors:  R J Hay
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-26

2.  Skin targeted lipid vesicles as novel nano-carrier of ketoconazole: characterization, in vitro and in vivo evaluation.

Authors:  Fang Guo; Jinping Wang; Man Ma; Fengping Tan; Nan Li
Journal:  J Mater Sci Mater Med       Date:  2015-04-01       Impact factor: 3.896

3.  Sensitivity of some strains of the genus Epidermophyton to different antifungal agents.

Authors:  F J Cabañes; L Abarca; M Bragulat; T Bruguera
Journal:  Mycopathologia       Date:  1989-03       Impact factor: 2.574

Review 4.  Overview of medically important antifungal azole derivatives.

Authors:  R A Fromtling
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

5.  Itraconazole, a new triazole that is orally active in aspergillosis.

Authors:  J Van Cutsem; F Van Gerven; M A Van de Ven; M Borgers; P A Janssen
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

Review 6.  Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications.

Authors:  C A Lyman; T J Walsh
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

7.  Application of ubiquinone systems and electrophoretic comparison of enzymes to identification of clinical isolates of Aspergillus fumigatus and several other species of Aspergillus.

Authors:  H Matsuda; S Kohno; S Maesaki; H Yamada; H Koga; M Tamura; H Kuraishi; J Sugiyama
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

8.  Determination and production of antimicrobial compounds by Aspergillus clavatonanicus strain MJ31, an endophytic fungus from Mirabilis jalapa L. using UPLC-ESI-MS/MS and TD-GC-MS analysis.

Authors:  Vineet Kumar Mishra; Ajit Kumar Passari; Preeti Chandra; Vincent Vineeth Leo; Brijesh Kumar; Sivakumar Uthandi; Sugitha Thankappan; Vijai Kumar Gupta; Bhim Pratap Singh
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.752

9.  Antimicrobial Activity of Quinoline-Based Hydroxyimidazolium Hybrids.

Authors:  Daniel Insuasty; Oscar Vidal; Anthony Bernal; Edgar Marquez; Juan Guzman; Braulio Insuasty; Jairo Quiroga; Laura Svetaz; Susana Zacchino; Gloria Puerto; Rodrigo Abonia
Journal:  Antibiotics (Basel)       Date:  2019-11-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.